Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
6 studies found for:    carraguard | "Sexually Transmitted Diseases"
Show Display Options
Rank Status Study
1 Completed Efficacy Study of the Vaginal Gel Carraguard to Prevent HIV Transmission
Conditions: HIV Infections;   AIDS;   Sexually Transmitted Diseases;   HIV Seroconversion
Intervention: Drug: Carraguard (PC-515)
2 Completed Safety, Acceptability and Preliminary Effectiveness of Carraguard™ (PC-515) in Preventing HIV/STI Transmission
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis
Intervention: Drug: Carraguard (PC-515)
3 Completed Safety and Acceptability of Carraguard™ Among HIV-Negative Couples in Thailand
Conditions: HIV Infections;   Chlamydia Trachomatis;   Nesseria Gonorrhea;   Trichomonas Vaginitis;   Syphilis
Intervention: Drug: Carraguard (PC-515)
4 Completed Safety, Acceptability and Preliminary Effectiveness of PC-515 for Vaginal Use as a Possible Microbicide
Conditions: HIV Infections;   Chlamydia Trachomatis;   Neisseria Gonorrhoeae;   Trichomonas Vaginitis;   Syphilis;   Herpes Simplex
Intervention: Drug: Carraguard  (PC-515)
5 Completed Safety and Acceptability of Carraguard® in HIV Positive Women and Men
Condition: HIV Infections
Intervention: Drug: Carraguard  (PC-515)
6 Completed A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected Women
Condition: HIV Infections
Intervention: Drug: Carraguard  (PC-515)

Indicates status has not been verified in more than two years